title: Liver transplant for hepatocellular cancer: very small tumors, very large tumors, and waiting time.
abstract: The role of liver transplant for treatment of early hepatocellular cancer (HCC) is no longer contested. However, its benefit relative to other therapies for patients with very early (<2 cm) HCC is still a matter of debate. Twenty years after the establishment of the Milan criteria, we are beginning to realize that the number and size of tumors may not be the best metric by which to prognosticate outcomes and allocate organs. A better assessment of tumor aggressiveness is clearly needed.
authors.affiliation: Division of Abdominal Organ Transplantation, Department of Surgery, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, L-590, Portland, OR 97239, USA.
authors.forename: Kayvan
authors.initials: K
authors.lastname: Roayaie
authors.affiliation: Liver Cancer Program, Hofstra-North Shore LIJ School of Medicine, Lenox Hill Hospital, New York, NY, USA. Electronic address: sasan.roayaie@gmail.com.
authors.forename: Sasan
authors.initials: S
authors.lastname: Roayaie
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000473:pathology* / Q000601:surgery*; D017115:Catheter Ablation; D018572:Disease-Free Survival; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology* / Q000601:surgery*; D016031:Liver Transplantation; D018579:Patient Selection; D016019:Survival Analysis; D013997:Time Factors; D014850:Waiting Lists
keywords: Drop out; Expansion; Milan criteria; Recurrence; Resection; UNOS stage 1